bioRxiv preprint doi: https://doi.org/10.1101/2020.01.06.892497; this version posted January 6, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Calpain-2 regulates hypoxia/HIF-induced amoeboid reprogramming and metastasis Veronika te Boekhorst1,2, Liying Jiang1, Marius Mählen2, Maaike Meerlo3, Gina Dunkel2, Franziska C. Durst1*, Yanjun Yang4, Herbert Levine4,5, Boudewijn M. T. Burgering3,6, Peter Friedl1, 2, 6 1David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2Dept. of Cell Biology, Radboud University Medical Centre, 6525GA Nijmegen, The Netherlands 3Dept. of Molecular Cancer Research Center of Molecular Medicine, UMC Utrecht, the Netherlands and Oncode Institute 4Dept. of Physics, Northeastern Univ. Boston MA 02115 5Center for Theoretical Biological Physics, Rice University Houston, TX 77005 6Cancer Genomics Center, 3584 CG Utrecht, The Netherlands * Current Address: Regensburg Center of Interventional Immunology (RCI), 93053 Regensburg Corresponding author:
[email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.06.892497; this version posted January 6, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Summary Hypoxia, through hypoxia inducible factor (HIF), drives cancer cell invasion and metastatic progression in various cancer types, leading to poor prognosis. In epithelial cancer, hypoxia further induces the transition to amoeboid cancer cell dissemination, yet the molecular mechanisms, relevance for metastasis, and effective interventions to combat hypoxia-induced amoeboid reprogramming remain unclear.